Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World's First Open-Source Real-Time PCR Thermocycler Launched

By LabMedica International staff writers
Posted on 16 Nov 2014
Priced at a tenth the cost of traditional cyclers, the low-cost qPCR thermocycler will especially benefit lesser-funded laboratories and can facilitate diagnostics in developing countries.

Chai Biotechnologies (Santa Clara, CA, USA), a biotech startup focused on making core molecular biological technologies more accessible while developing powerful tools for synthetic biologists, now offers Open qPCR—the world's first open-source real-time PCR thermocycler. More...
The new relative quantitative PCR (qPCR) machine has now been launched via a KickStarter crowdfunding campaign.

As with real-time PCR used in diagnostic and research applications, Open qPCR is capable of genotyping, pathogen presence/absence detection, and relative DNA quantification. With its current 16-well sample capacity (100 µL or 200 µL tubes), it is primarily focused on diagnostics related applications.

The instrument is currently available for USD 1,499 as part of the campaign, and is expected to ship in March 2015. "With Real-Time PCR thermocyclers typically costing USD 20,000 and up, this technology was simply unaffordable to lesser funded university labs, institutes in developing countries dealing with emerging epidemics, and the growing DIYbio [do-it-yourself biology] maker-movement," said Josh Perfetto, founder and chief executive of Chai, "With Open qPCR, we've lowered the cost of the Real-Time PCR reaction by an order of magnitude." CEO Perfetto was also a co-creator of the earlier OpenPCR project, which made the world's first open-source endpoint PCR thermocycler available in 2011.

Features of Open qPCR include: Visual, web-based interface for protocol editing, plate layout, and results interpretation; Integrated touch screen supports field use; Ethernet, Wi-Fi, and USB connectivity; Open API supports automation applications; Low power mode for isothermal amplification applications; Complete hardware design and software, to be released as open source when machine ships.

The KickStarter campaign runs until December 4, 2014. The campaign is also raising funds to donate instruments to Ebola clinics in western Africa.

Related Links:

Chai Biotechnologies
Open qPCR 



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.